Sentinel Lymph Node Biopsy for Cancer

Sentinel lymph node biopsy removes and tests the first lymph node where cancer from the primary tumor would drain to determine whether it has started spreading beyond the original site. If the sentinel node is clean the remaining nodes stay untouched sparing the patient from full dissection and its lifelong complication of lymphedema. SLNB is standard for breast cancer and melanoma staging and increasingly used in cervical, endometrial, and head and neck cancers.

According to Dr. Sandeep Nayak, Best cancer treatment in Bangalore, “We used to remove 15-20 axillary nodes from every breast cancer patient. Most came back clean but the woman still got arm swelling for life. Now we check one or two nodes first. Clean sentinel means the arm stays normal and the patient walks out without a complication she never needed.”

Sentinel node is the first stop cancer would reach if it left the tumor. Testing it tells the surgeon whether the disease has started travelling or is still contained.

• Tracer injection: Radioactive tracer or blue dye injected near the tumor travels through lymphatic channels collecting in the first draining node. Surgeon follows the gamma probe or blue stain to locate the sentinel precisely.
• Node removal: One to three sentinel nodes removed during cancer surgery itself and sent for pathology while the patient is still under anesthesia. Adds 15-20 minutes to the operation.
• Negative result: No cancer in sentinel. Remaining nodes left alone. Lymphedema risk drops from 20-30% with full clearance to 5-7% with SLNB. Patient keeps arm or leg function instead of developing permanent swelling.
• Positive result: Cancer found in sentinel. Surgeon either proceeds with complete node dissection during the same operation or oncologist recommends radiation to the nodal basin depending on cancer type and extent of involvement.

Your oncologist determines SLNB need through cancer staging assessment before surgery.

SLNB applies when nodes haven’t been proven positive yet and the result changes what happens next.

• Breast cancer: Standard for clinically node-negative early breast cancer where preoperative ultrasound shows no suspicious axillary nodes. Woman keeps her arm function instead of developing permanent swelling because someone checked one node before clearing twenty.
• Melanoma: Recommended for melanomas thicker than 0.8 mm with ulceration or anything above 1 mm. Sentinel status is the single strongest prognostic factor deciding whether the patient needs adjuvant immunotherapy or not.
• Gynecological cancers: Replacing full pelvic lymphadenectomy in early cervical and endometrial cancers. Reduces leg lymphedema and surgical morbidity without compromising staging accuracy. Concept is same, just different body region.
• When it’s not done: Nodes already confirmed positive on FNAC or biopsy before surgery. No point mapping the sentinel when the answer is already known. Also skipped in inflammatory breast cancer or after prior axillary surgery where lymphatic mapping becomes unreliable.

Understanding how imaging scans each answer different staging questions explains why sentinel biopsy adds tissue-level confirmation that no scan provides with the same accuracy.

Dr. Sandeep Nayak performs sentinel biopsy using dual-tracer technique with radioactive colloid and blue dye achieving identification rates above 97%. MACS Clinic offers intraoperative frozen section so the result is available while the patient is still on the table and the plan adjusts in real time.

Breast cancer patient here gets SLNB during lumpectomy itself. Clean sentinel, arm stays normal, home in two days. Positive sentinel, next steps decided before she wakes up. No second surgery, no waiting weeks for answers.

Call +91 8035740000 to book your consultation.

References

1. Sentinel lymph node biopsy — National Cancer Institute
2. Lymph node staging in cancer — World Health Organization